查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1678488

全球臨床前影像市場：市場規模、佔有率、趨勢分析（按產品、應用、最終用途和地區）、細分市場預測（2025-2030 年）

Preclinical Imaging Market Size, Share & Trends Analysis Report By Product (Devices: CT, MRI, PET/SPECT, Multi-modal, Optical ), By Application (Research & Development, Drug Discovery), By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

臨床前影像市場的成長與趨勢：

根據Grand View Research, Inc.的最新報告，全球臨床前影像市場規模預計到2030年將達到59.6億美元，2025年至2030年期間的複合年成長率為4.36%。

大量的研發投入正在推動世界各地的研究計劃。因此，對臨床前成像的需求正在穩步成長。製藥、生物技術、生命科學、醫療設備和化妝品是影像模式在研究和開發中廣泛應用的應用領域。此外，獸醫診所和教育機構也正在為該市場創造新的需求。

核子醫學技術（主要是正子斷層掃描（PET）和單光子發射電腦斷層掃描（SPECT））、光學影像、微電腦斷層掃描（CT）、微型磁振造影（MRI）、光聲斷層掃描（PAT）和超音波是最適合小動物體內影像應用的方式。每種方式都有其優點和缺點。多重模式儀器旨在提供所研究病理學過程的互補訊息，正迅速變得越來越流行，旨在克服每種成像方式固有的局限性。微型 CT 和微型 MRI 等高解析度模式與微型 PET 和微型 SPECT 等提供功能資訊的敏感技術的結合，有望拓寬感染疾病、腫瘤學、心臟病循環系統和神經病學等關鍵領域的研究視野，有助於了解疾病的潛在機制，並為評估新化學實體和候選藥物提供高效而獨特的工具，從而促進全球市場的成長。

全球市場的主要競爭對手正在採取各種措施來增強產品系列，包括推出新產品和加強其製造能力。例如，在2023年2月舉行的第75屆印度放射和成像協會上，富士膠片印度公司宣布了設備和服務的發展。該公司於2023年2月2日至5日在阿姆利則舉行的活動中展示了其尖端診斷工具。最近推出的核磁共振造影系統APERTO Lucent Non DICOM印表機APEOS、超音波診斷設備Arietta 650 DeepInsight和Arietta 850 DeepInsight都是新產品組合的一部分。智慧型手機應用程式「FUJIFILM Connect」也已發布。

此外，用於癌症研究和監測應用的高通量超音波成像系統的進步將促進市場的發展。 2022 年 4 月，珀金埃爾默宣布擴展到即時影像分析領域，包括推出 Vega，這是一款手持式超音波成像系統，具有全自動技術和高通量功能，可加速癌症、腎臟和肝臟疾病以及心臟病學等領域的非侵入性臨床研究和藥物發現。人們鼓勵使用非侵入性影像方法，因為它們減少了侵入性手術的需要，同時最大限度地減少了動物的不適。正是由於這種倫理考慮，臨床前成像技術才得以被採用。

臨床前影像市場：概述

  • 光學成像領域在 2024 年佔據了 13.6% 的最大收益佔有率，這得益於其在小動物成像和藥物發現計劃中的廣泛應用。
  • 根據應用，研發部門在 2024 年佔據了最大的收益佔有率。
  • 製藥和生物技術公司部門在 2024 年佔據最大的收益佔有率，為 39.9%。近年來，生物技術公司對臨床前成像的需求穩步成長，預計還將繼續成長。
  • 北美臨床前影像市場佔最大收益佔有率，2024 年為 30.1%。

目錄

第1章 分析方法及範圍

第 2 章執行摘要

3. 臨床前影像市場：促進因素、趨勢與範圍

  • 市場聯動展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制分析
  • 臨床前影像市場：分析工具
    • 產業分析：波特五力分析
    • PESTEL 分析

第 4 章臨床前影像市場：按產品分類的估計和趨勢分析

  • 細分儀表板
  • 臨床前影像市場：按產品的變化分析
  • 臨床前影像市場：按產品分類的市場規模預測和趨勢分析（2018-2030 年）
  • CT
  • MRI
  • PET/SPECT
  • 多模態
  • 光學
  • 超音波
  • 光聲
  • 試劑
  • 服務

第 5 章臨床前影像市場：按應用進行的估計和趨勢分析

  • 細分儀表板
  • 臨床前影像市場：按應用進行的變化分析
  • 臨床前影像市場：按應用分類的市場規模預測和趨勢分析（2018-2030 年）
  • 研究與開發
  • 藥物研發

6. 臨床前影像市場：按最終用途分類的估計和趨勢分析

  • 細分儀表板
  • 臨床前成像市場：按最終用途進行的變化分析
  • 臨床前影像市場：按最終用途分類的市場規模預測和趨勢分析（2018-2030 年）
  • 製藥和生物技術公司
  • 研究所
  • 其他

7. 臨床前影像市場：區域估計和趨勢分析（按產品、應用和最終用途）

  • 各地區市場佔有率分析（2023 年及 2030 年）
  • 市場儀表板：按地區
  • 全球市場概況：按地區
  • 市場規模預測及趨勢分析（2018-2030年）
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭格局

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司/競爭對手分類
  • 主要企業市場佔有率分析（2025年）
  • 公司地位分析
  • 公司分類（新興企業、創新企業、領導者）
  • 公司簡介
    • Bruker Corporation
    • Siemens AG
    • General Electric（GE）
    • TriFoil Imaging
    • PerkinElmer, Inc.
    • VisualSonics Inc.（Fujifilm）
    • Mediso Ltd.
    • Agilent Technologies
    • MILabs BV
    • MR Solutions
    • Molecubes
Product Code: 978-1-68038-881-7

Preclinical Imaging Market Growth & Trends:

The global preclinical imaging market size is estimated to reach USD 5.96 billion by 2030, registering to grow at a CAGR of 4.36% from 2025 to 2030 according to a new report by Grand View Research, Inc. Heavy investments in research and development are encouraging research projects worldwide. As a result, the demand for preclinical imaging is steadily increasing. Pharmaceuticals, biotechnology, life sciences, medical devices, and cosmetics are wide application areas, where imaging modalities are widely used in research and development. Furthermore, veterinary hospitals and educational institutions also create an additional demand for this market.

Nuclear medicine techniques (primarily, positron emission tomography (PET) and single photon emission computed tomography (SPECT)), optical imaging, micro-computed tomography (CT), micro magnetic resonance imaging (MRI), Photoacoustic tomography (PAT), and ultrasound are the most suitable modalities for small-animal in vivo imaging applications. Each modality has its own set of benefits and drawbacks. The multimodality devices designed to give complementary information on the pathophysiological process under research have rapidly gained popularity, seeking to overcome the inherent limits of each imaging modality. The combination of high-resolution modalities such as micro-CT and micro-MRI with highly sensitive techniques that provide functional information like micro-PET or micro-SPECT is expected to broaden the horizons of research in key areas like infection, oncology, cardiology, and neurology, contributing not only to the understanding of disease underlying mechanisms but also providing efficient and unique tools for evaluating new chemical entities and candidate drugs, thus boosting the global market growth.

The global market's prominent competitors are undertaking different initiatives for enhancing their product portfolio with novel product launches and enhancing their manufacturing capacity. For instance, In February 2023, at the 75th National Conference of the Indian Radiological and Imaging Association, FUJIFILM India announced the development of its equipment and service offerings. The company demonstrated cutting-edge diagnostic tools at the event in Amritsar from February 2-5, 2023. The recently released MRI machine APERTO Lucent Non DICOM printer APEOS and the ultrasound devices Arietta 650 DeepInsight and Arietta 850 DeepInsight are all components of the new portfolio. A smartphone application for assistance and guidance called "FUJIFILM Connect" was additionally released by the company.

Moreover, the advancements in the high-throughput ultrasound imaging system used in the application of cancer research and studies boost the market. In April 2022, the Vega imaging system, a handheld ultrasound system with fully automated technology and high-throughput capacity, which can speed up non-invasive clinical research and drug discovery in the fields of cancer, kidney and liver disease, and heart disease, was launched by PerkinElmer as an aspect of the company's announcement of a broadening of its live image analysis. The use of non-invasive imaging methods is encouraged since they reduce the need for invasive operations while minimizing animals' discomfort to a minimum. Preclinical imaging techniques have been adopted as a result of this ethical consideration.

Preclinical Imaging Market Report Highlights:

  • The optical imaging segment held the largest revenue share of 13.6% in 2024 owing to their wide usage in small animal imaging and new drug discovery projects.
  • In terms of application, the research & development segment captured the largest revenue share in 2024.
  • The pharma and biotech companies segment captured the largest revenue share of 39.9% in 2024. The demand for pre-clinical imaging in biotech companies has been steadily increasing in recent years and is expected to continue growing in the coming years.
  • North America preclinical imaging market held the largest revenue share of 30.1% in 2024.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Application
    • 1.2.3. End Use
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Application outlook
    • 2.2.3. End use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Preclinical Imaging Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Technological advancements
      • 3.2.1.2. Growing number of investments and funding in research and development
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Strict regulatory framework
  • 3.3. Preclinical Imaging Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Preclinical Imaging Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Preclinical Imaging Product Market Movement Analysis
  • 4.3. Global Preclinical Imaging Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. CT
    • 4.4.1. CT market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. MRI
    • 4.5.1. MRI market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. PET/SPECT
    • 4.6.1. PET/SPECT market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.7. Multi Modal
    • 4.7.1. Multi modal market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.8. Optical
    • 4.8.1. Optical market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.9. Ultrasound
    • 4.9.1. Ultrasound market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.10. Photoacoustic
    • 4.10.1. Photoacoustic market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.11. Reagents
    • 4.11.1. Reagents market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.12. Services
    • 4.12.1. Services market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Preclinical Imaging Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Preclinical Imaging Application Market Movement Analysis
  • 5.3. Global Preclinical Imaging Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 5.4. Research and Development
    • 5.4.1. Research and development market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Drug Discovery
    • 5.5.1. Drug discovery market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Preclinical Imaging Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Preclinical Imaging End Use Market Movement Analysis
  • 6.3. Global Preclinical Imaging Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 6.4. Pharma and Biotech Companies
    • 6.4.1. Pharma and biotech companies market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Research Institutes
    • 6.5.1. Research institutes market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Others
    • 6.6.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Preclinical Imaging Market: Regional Estimates & Trend Analysis By Product, Application, End Use

  • 7.1. Regional Market Share Analysis, 2025 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.5. North America
    • 7.5.1. U.S.
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Competitive scenario
      • 7.5.1.3. Regulatory framework
      • 7.5.1.4. Reimbursement structure
      • 7.5.1.5. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.2. Canada
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Competitive scenario
      • 7.5.2.3. Regulatory framework
      • 7.5.2.4. Reimbursement structure
      • 7.5.2.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.3. Mexico
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Competitive scenario
      • 7.5.3.3. Regulatory framework
      • 7.5.3.4. Reimbursement structure
      • 7.5.3.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Europe
    • 7.6.1. UK
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Competitive scenario
      • 7.6.1.3. Regulatory framework
      • 7.6.1.4. Reimbursement structure
      • 7.6.1.5. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.2. Germany
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Competitive scenario
      • 7.6.2.3. Regulatory framework
      • 7.6.2.4. Reimbursement structure
      • 7.6.2.5. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.3. France
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Competitive scenario
      • 7.6.3.3. Regulatory framework
      • 7.6.3.4. Reimbursement structure
      • 7.6.3.5. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.4. Italy
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Competitive scenario
      • 7.6.4.3. Regulatory framework
      • 7.6.4.4. Reimbursement structure
      • 7.6.4.5. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.5. Spain
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Competitive scenario
      • 7.6.5.3. Regulatory framework
      • 7.6.5.4. Reimbursement structure
      • 7.6.5.5. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.6. Norway
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Competitive scenario
      • 7.6.6.3. Regulatory framework
      • 7.6.6.4. Reimbursement structure
      • 7.6.6.5. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.7. Sweden
      • 7.6.7.1. Key country dynamics
      • 7.6.7.2. Competitive scenario
      • 7.6.7.3. Regulatory framework
      • 7.6.7.4. Reimbursement structure
      • 7.6.7.5. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.8. Denmark
      • 7.6.8.1. Key country dynamics
      • 7.6.8.2. Competitive scenario
      • 7.6.8.3. Regulatory framework
      • 7.6.8.4. Reimbursement structure
      • 7.6.8.5. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. Asia Pacific
    • 7.7.1. Japan
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Competitive scenario
      • 7.7.1.3. Regulatory framework
      • 7.7.1.4. Reimbursement structure
      • 7.7.1.5. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.2. China
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Competitive scenario
      • 7.7.2.3. Regulatory framework
      • 7.7.2.4. Reimbursement structure
      • 7.7.2.5. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.3. India
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Competitive scenario
      • 7.7.3.3. Regulatory framework
      • 7.7.3.4. Reimbursement structure
      • 7.7.3.5. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.4. Australia
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Competitive scenario
      • 7.7.4.3. Regulatory framework
      • 7.7.4.4. Reimbursement structure
      • 7.7.4.5. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.5. South Korea
      • 7.7.5.1. Key country dynamics
      • 7.7.5.2. Competitive scenario
      • 7.7.5.3. Regulatory framework
      • 7.7.5.4. Reimbursement structure
      • 7.7.5.5. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.6. Thailand
      • 7.7.6.1. Key country dynamics
      • 7.7.6.2. Competitive scenario
      • 7.7.6.3. Regulatory framework
      • 7.7.6.4. Reimbursement structure
      • 7.7.6.5. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8. Latin America
    • 7.8.1. Brazil
      • 7.8.1.1. Key country dynamics
      • 7.8.1.2. Competitive scenario
      • 7.8.1.3. Regulatory framework
      • 7.8.1.4. Reimbursement structure
      • 7.8.1.5. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.2. Argentina
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Competitive scenario
      • 7.8.2.3. Regulatory framework
      • 7.8.2.4. Reimbursement structure
      • 7.8.2.5. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.9. MEA
    • 7.9.1. South Africa
      • 7.9.1.1. Key country dynamics
      • 7.9.1.2. Competitive scenario
      • 7.9.1.3. Regulatory framework
      • 7.9.1.4. Reimbursement structure
      • 7.9.1.5. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.2. Saudi Arabia
      • 7.9.2.1. Key country dynamics
      • 7.9.2.2. Competitive scenario
      • 7.9.2.3. Regulatory framework
      • 7.9.2.4. Reimbursement structure
      • 7.9.2.5. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.3. UAE
      • 7.9.3.1. Key country dynamics
      • 7.9.3.2. Competitive scenario
      • 7.9.3.3. Regulatory framework
      • 7.9.3.4. Reimbursement structure
      • 7.9.3.5. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.4. Kuwait
      • 7.9.4.1. Key country dynamics
      • 7.9.4.2. Competitive scenario
      • 7.9.4.3. Regulatory framework
      • 7.9.4.4. Reimbursement structure
      • 7.9.4.5. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Key company market share analysis, 2025
  • 8.4. Company Position Analysis
  • 8.5. Company Categorization (Emerging Players, Innovators and Leaders)
  • 8.6. Company Profiles
    • 8.6.1. Bruker Corporation
      • 8.6.1.1. Company overview
      • 8.6.1.2. Financial performance
      • 8.6.1.3. Product benchmarking
      • 8.6.1.4. Strategic initiatives
    • 8.6.2. Siemens A.G.
      • 8.6.2.1. Company overview
      • 8.6.2.2. Financial performance
      • 8.6.2.3. Product benchmarking
      • 8.6.2.4. Strategic initiatives
    • 8.6.3. General Electric (GE)
      • 8.6.3.1. Company overview
      • 8.6.3.2. Financial performance
      • 8.6.3.3. Product benchmarking
      • 8.6.3.4. Strategic initiatives
    • 8.6.4. TriFoil Imaging
      • 8.6.4.1. Company overview
      • 8.6.4.2. Financial performance
      • 8.6.4.3. Product benchmarking
      • 8.6.4.4. Strategic initiatives
    • 8.6.5. PerkinElmer, Inc.
      • 8.6.5.1. Company overview
      • 8.6.5.2. Financial performance
      • 8.6.5.3. Product benchmarking
      • 8.6.5.4. Strategic initiatives
    • 8.6.6. VisualSonics Inc. (Fujifilm)
      • 8.6.6.1. Company overview
      • 8.6.6.2. Financial performance
      • 8.6.6.3. Product benchmarking
      • 8.6.6.4. Strategic initiatives
    • 8.6.7. Mediso Ltd.
      • 8.6.7.1. Company overview
      • 8.6.7.2. Financial performance
      • 8.6.7.3. Product benchmarking
      • 8.6.7.4. Strategic initiatives
    • 8.6.8. Agilent Technologies
      • 8.6.8.1. Company overview
      • 8.6.8.2. Financial performance
      • 8.6.8.3. Product benchmarking
      • 8.6.8.4. Strategic initiatives
    • 8.6.9. MILabs B.V.
      • 8.6.9.1. Company overview
      • 8.6.9.2. Financial performance
      • 8.6.9.3. Product benchmarking
      • 8.6.9.4. Strategic initiatives
    • 8.6.10. MR Solutions
      • 8.6.10.1. Company overview
      • 8.6.10.2. Financial performance
      • 8.6.10.3. Product benchmarking
      • 8.6.10.4. Strategic initiatives
    • 8.6.11. Molecubes
      • 8.6.11.1. Company overview
      • 8.6.11.2. Financial performance
      • 8.6.11.3. Product benchmarking
      • 8.6.11.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 North America preclinical imaging market, By country, 2018 - 2030 (USD Million)
  • Table 3 North America preclinical imaging market, By product, 2018 - 2030 (USD Million)
  • Table 4 North America preclinical imaging market, By application, 2018 - 2030 (USD Million)
  • Table 5 North America preclinical imaging market, By end use, 2018 - 2030 (USD Million)
  • Table 6 U.S. preclinical imaging market, By product, 2018 - 2030 (USD Million)
  • Table 7 U.S. preclinical imaging market, By application, 2018 - 2030 (USD Million)
  • Table 8 U.S. preclinical imaging market, By end use, 2018 - 2030 (USD Million)
  • Table 9 Canada preclinical imaging market, By product, 2018 - 2030 (USD Million)
  • Table 10 Canada preclinical imaging market, By application, 2018 - 2030 (USD Million)
  • Table 11 Canada preclinical imaging market, By end use, 2018 - 2030 (USD Million)
  • Table 12 Mexico preclinical imaging market, By product, 2018 - 2030 (USD Million)
  • Table 13 Mexico preclinical imaging market, By application, 2018 - 2030 (USD Million)
  • Table 14 Mexico preclinical imaging market, By end use, 2018 - 2030 (USD Million)
  • Table 15 Europe preclinical imaging market, By country, 2018 - 2030 (USD Million)
  • Table 16 Europe preclinical imaging market, By product, 2018 - 2030 (USD Million)
  • Table 17 Europe preclinical imaging market, By application, 2018 - 2030 (USD Million)
  • Table 18 Europe preclinical imaging market, By end use, 2018 - 2030 (USD Million)
  • Table 19 UK preclinical imaging market, By product, 2018 - 2030 (USD Million)
  • Table 20 UK preclinical imaging market, By application, 2018 - 2030 (USD Million)
  • Table 21 UK preclinical imaging market, By end use, 2018 - 2030 (USD Million)
  • Table 22 Germany preclinical imaging market, By product, 2018 - 2030 (USD Million)
  • Table 23 Germany preclinical imaging market, By application, 2018 - 2030 (USD Million)
  • Table 24 Germany preclinical imaging market, By end use, 2018 - 2030 (USD Million)
  • Table 25 France preclinical imaging market, By product, 2018 - 2030 (USD Million)
  • Table 26 France preclinical imaging market, By application, 2018 - 2030 (USD Million)
  • Table 27 France preclinical imaging market, By end use, 2018 - 2030 (USD Million)
  • Table 28 Italy preclinical imaging market, By product, 2018 - 2030 (USD Million)
  • Table 29 Italy preclinical imaging market, By application, 2018 - 2030 (USD Million)
  • Table 30 Italy preclinical imaging market, By end use, 2018 - 2030 (USD Million)
  • Table 31 Denmark preclinical imaging market, By product, 2018 - 2030 (USD Million)
  • Table 32 Denmark preclinical imaging market, By application, 2018 - 2030 (USD Million)
  • Table 33 Denmark preclinical imaging market, By end use, 2018 - 2030 (USD Million)
  • Table 34 Sweden preclinical imaging market, By product, 2018 - 2030 (USD Million)
  • Table 35 Sweden preclinical imaging market, By application, 2018 - 2030 (USD Million)
  • Table 36 Sweden preclinical imaging market, By end use, 2018 - 2030 (USD Million)
  • Table 37 Norway preclinical imaging market, By product, 2018 - 2030 (USD Million)
  • Table 38 Norway preclinical imaging market, By application, 2018 - 2030 (USD Million)
  • Table 39 Norway preclinical imaging market, By end use, 2018 - 2030 (USD Million)
  • Table 40 Asia Pacific preclinical imaging market, By country, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific preclinical imaging market, By product, 2018 - 2030 (USD Million)
  • Table 42 Asia Pacific preclinical imaging market, By application, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific preclinical imaging market, By end use, 2018 - 2030 (USD Million)
  • Table 44 Japan preclinical imaging market, By product, 2018 - 2030 (USD Million)
  • Table 45 Japan preclinical imaging market, By application, 2018 - 2030 (USD Million)
  • Table 46 Japan preclinical imaging market, By end use, 2018 - 2030 (USD Million)
  • Table 47 China preclinical imaging market, By product, 2018 - 2030 (USD Million)
  • Table 48 China preclinical imaging market, By application, 2018 - 2030 (USD Million)
  • Table 49 China preclinical imaging market, By end use, 2018 - 2030 (USD Million)
  • Table 50 India preclinical imaging market, By product, 2018 - 2030 (USD Million)
  • Table 51 India preclinical imaging market, By application, 2018 - 2030 (USD Million)
  • Table 52 India preclinical imaging market, By end use, 2018 - 2030 (USD Million)
  • Table 53 Australia preclinical imaging market, By product, 2018 - 2030 (USD Million)
  • Table 54 Australia preclinical imaging market, By application, 2018 - 2030 (USD Million)
  • Table 55 Australia preclinical imaging market, By end use, 2018 - 2030 (USD Million)
  • Table 56 South Korea preclinical imaging market, By product, 2018 - 2030 (USD Million)
  • Table 57 South Korea preclinical imaging market, By application, 2018 - 2030 (USD Million)
  • Table 58 South Korea preclinical imaging market, By end use, 2018 - 2030 (USD Million)
  • Table 59 Thailand preclinical imaging market, By product, 2018 - 2030 (USD Million)
  • Table 60 Thailand preclinical imaging market, By application, 2018 - 2030 (USD Million)
  • Table 61 Thailand preclinical imaging market, By end use, 2018 - 2030 (USD Million)
  • Table 62 Latin America preclinical imaging market, By Country, 2018 - 2030 (USD Million)
  • Table 63 Latin America preclinical imaging market, By product, 2018 - 2030 (USD Million)
  • Table 64 Latin America preclinical imaging market, By application, 2018 - 2030 (USD Million)
  • Table 65 Latin America preclinical imaging market, By end use, 2018 - 2030 (USD Million)
  • Table 66 Brazil preclinical imaging market, By product, 2018 - 2030 (USD Million)
  • Table 67 Brazil preclinical imaging market, By application, 2018 - 2030 (USD Million)
  • Table 68 Brazil preclinical imaging market, By end use, 2018 - 2030 (USD Million)
  • Table 69 Argentina preclinical imaging market, By product, 2018 - 2030 (USD Million)
  • Table 70 Argentina preclinical imaging market, By application, 2018 - 2030 (USD Million)
  • Table 71 Argentina preclinical imaging market, By end use, 2018 - 2030 (USD Million)
  • Table 72 Middle East & Africa preclinical imaging market, By country, 2018 - 2030 (USD Million)
  • Table 73 Middle East & Africa preclinical imaging market, By product, 2018 - 2030 (USD Million)
  • Table 74 Middle East & Africa preclinical imaging market, By application, 2018 - 2030 (USD Million)
  • Table 75 Middle East & Africa preclinical imaging market, By end use, 2018 - 2030 (USD Million)
  • Table 76 South Africa preclinical imaging market, By product, 2018 - 2030 (USD Million)
  • Table 77 South Africa preclinical imaging market, By application, 2018 - 2030 (USD Million)
  • Table 78 South Africa preclinical imaging market, By end use, 2018 - 2030 (USD Million)
  • Table 79 Saudi Arabia preclinical imaging market, By product, 2018 - 2030 (USD Million)
  • Table 80 Saudi Arabia preclinical imaging market, By application, 2018 - 2030 (USD Million)
  • Table 81 Saudi Arabia preclinical imaging market, By end use, 2018 - 2030 (USD Million)
  • Table 82 UAE preclinical imaging market, By product, 2018 - 2030 (USD Million)
  • Table 83 UAE preclinical imaging market, By application, 2018 - 2030 (USD Million)
  • Table 84 UAE preclinical imaging market, By end use, 2018 - 2030 (USD Million)
  • Table 85 Kuwait preclinical imaging market, By product, 2018 - 2030 (USD Million)
  • Table 86 Kuwait preclinical imaging market, By application, 2018 - 2030 (USD Million)
  • Table 87 Kuwait preclinical imaging market, By end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Dermatology imaging devices market: Market outlook
  • Fig. 14 Dermatology imaging devices market competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Penetration and growth prospect mapping
  • Fig. 18 Industry value chain analysis
  • Fig. 19 Preclinical imaging market driver impact
  • Fig. 20 Preclinical imaging restraint impact
  • Fig. 21 Preclinical imaging market: product movement analysis
  • Fig. 22 Preclinical imaging market: product outlook and key takeaways
  • Fig. 23 CT market estimates and forecast, 2018 - 2030
  • Fig. 24 MRI market estimates and forecast, 2018 - 2030
  • Fig. 25 PET/SPECT market estimates and forecast, 2018 - 2030
  • Fig. 26 Multi Modal market estimates and forecast, 2018 - 2030
  • Fig. 27 Optical market estimates and forecast, 2018 - 2030
  • Fig. 28 Ultrasound market estimates and forecast, 2018 - 2030
  • Fig. 29 Photoacoustic market estimates and forecast, 2018 - 2030
  • Fig. 30 Reagents market estimates and forecast, 2018 - 2030
  • Fig. 31 Services market estimates and forecast, 2018 - 2030
  • Fig. 32 Preclinical imaging market: application movement analysis
  • Fig. 33 Preclinical imaging market: application outlook and key takeaways
  • Fig. 34 Research and development market estimates and forecast, 2018 - 2030
  • Fig. 35 Drug discovery market estimates and forecast, 2018 - 2030
  • Fig. 36 Preclinical imaging market: end use movement analysis
  • Fig. 37 Preclinical imaging market: end use outlook and key takeaways
  • Fig. 38 Pharma and biotech companies market estimates and forecast, 2018 - 2030
  • Fig. 39 Research institutes market estimates and forecast, 2018 - 2030
  • Fig. 40 Global Dermatology imaging devices market: regional movement analysis
  • Fig. 41 Global Dermatology imaging devices market: regional outlook and key takeaways
  • Fig. 42 North America
  • Fig. 43 North America market estimates and forecast, 2018 - 2030
  • Fig. 44 U.S.
  • Fig. 45 U.S. market estimates and forecast, 2018 - 2030
  • Fig. 46 Canada
  • Fig. 47 Canada market estimates and forecast, 2018 - 2030
  • Fig. 48 Mexico
  • Fig. 49 Mexico market estimates and forecast, 2018 - 2030
  • Fig. 50 Europe
  • Fig. 51 Europe. market estimates and forecast, 2018 - 2030
  • Fig. 52 UK
  • Fig. 53 UK market estimates and forecast, 2018 - 2030
  • Fig. 54 Germany
  • Fig. 55 Germany market estimates and forecast, 2018 - 2030
  • Fig. 56 France
  • Fig. 57 France market estimates and forecast, 2018 - 2030
  • Fig. 58 Italy
  • Fig. 59 Italy market estimates and forecast, 2018 - 2030
  • Fig. 60 Spain
  • Fig. 61 Spain market estimates and forecast, 2018 - 2030
  • Fig. 62 Denmark
  • Fig. 63 Denmark market estimates and forecast, 2018 - 2030
  • Fig. 64 Sweden
  • Fig. 65 Sweden market estimates and forecast, 2018 - 2030
  • Fig. 66 Norway
  • Fig. 67 Norway market estimates and forecast, 2018 - 2030
  • Fig. 68 Asia Pacific
  • Fig. 69 Asia Pacific market estimates and forecast, 2018 - 2030
  • Fig. 70 Japan
  • Fig. 71 Japan market estimates and forecast, 2018 - 2030
  • Fig. 72 China
  • Fig. 73 China market estimates and forecast, 2018 - 2030
  • Fig. 74 India
  • Fig. 75 India market estimates and forecast, 2018 - 2030
  • Fig. 76 South Korea
  • Fig. 77 South Korea market estimates and forecast, 2018 - 2030
  • Fig. 78 Thailand
  • Fig. 79 Thailand market estimates and forecast, 2018 - 2030
  • Fig. 80 Australia
  • Fig. 81 Australia market estimates and forecast, 2018 - 2030
  • Fig. 82 Latin America
  • Fig. 83 Latin America market estimates and forecast, 2018 - 2030
  • Fig. 84 Brazil
  • Fig. 85 Brazil market estimates and forecast, 2018 - 2030
  • Fig. 86 Argentina
  • Fig. 87 Argentina market estimates and forecast, 2018 - 2030
  • Fig. 88 Middle East and Africa
  • Fig. 89 Middle East and Africa. market estimates and forecast, 2018 - 2030
  • Fig. 90 Saudi Arabia
  • Fig. 91 Saudi Arabia market estimates and forecast, 2018 - 2030
  • Fig. 92 South Africa
  • Fig. 93 South Africa market estimates and forecast, 2018 - 2030
  • Fig. 94 UAE
  • Fig. 95 UAE market estimates and forecast, 2018 - 2030
  • Fig. 96 Kuwait
  • Fig. 97 Kuwait market estimates and forecast, 2018 - 2030
  • Fig. 98 Participant categorization- Preclinical imaging market
  • Fig. 99 Market share of key market players- Preclinical imaging market